Okajima K, Ishii M
Department of Laboratory Medicine, Kumamoto University School of Medicine, Japan.
Int J Hematol. 1999 Feb;69(2):129-32.
A male patient presented with life-threatening bleeding induced by autoantibody-induced factor VII (F.VII) deficiency. This patient had macroscopic hematuria, skin ecchymosis, gastrointestinal bleeding, and a neck hematoma that was causing disturbed respiration. He developed acute renal failure and acute hepatic failure, probably due to obstruction of the ureters and the biliary tract, respectively. Although activated partial thromboplastin time was normal, prothrombin time (PT) was remarkably prolonged at 71.8 seconds compared to 14.0 seconds in a normal control. Both the immunoreactive level of F.VII antigen and the F.VII activity of the patient's plasma samples were < 1.0% of normal. Although an equal part of normal plasma was added to the patient's plasma, PT was not corrected. The patient's plasma inhibited F.VII activity. These findings suggested the presence of a plasma inhibitor for F.VII. After administration of large doses of methylprednisolone, PT was gradually shortened and plasma levels of F.VII increased over time. Bleeding, acute renal failure, and acute hepatic failure improved markedly following the steroid treatment. These observations suggest that life-threatening bleeding can be induced by autoantibody-induced F.VII deficiency and that immunosuppressive therapy using large doses of steroid can be successful in inhibiting the production of the autoantibody.
一名男性患者因自身抗体诱导的凝血因子 VII(F.VII)缺乏而出现危及生命的出血。该患者有肉眼血尿、皮肤瘀斑、胃肠道出血以及导致呼吸障碍的颈部血肿。他分别因输尿管和胆道梗阻出现了急性肾衰竭和急性肝衰竭。尽管活化部分凝血活酶时间正常,但凝血酶原时间(PT)显著延长,达到 71.8 秒,而正常对照为 14.0 秒。患者血浆样本中 F.VII 抗原的免疫反应水平和 F.VII 活性均<正常水平的 1.0%。尽管向患者血浆中加入了等量的正常血浆,但 PT 并未得到纠正。患者血浆抑制 F.VII 活性。这些发现提示存在 F.VII 的血浆抑制剂。给予大剂量甲泼尼龙后,PT 逐渐缩短,F.VII 的血浆水平随时间升高。类固醇治疗后,出血、急性肾衰竭和急性肝衰竭均明显改善。这些观察结果表明,自身抗体诱导的 F.VII 缺乏可导致危及生命的出血,大剂量类固醇免疫抑制治疗可成功抑制自身抗体的产生。